Kim J, Kundu M, Viollet B, et al
BPC-157 vs LL-37 BPC-157 and LL-37 are both studied for wound healing but through distinct mechanisms: BPC-157 promotes tissue repair through angiogenesis, fibroblast activation, and nitric oxide modulation
It works by increasing insulin production, reducing glucagon levels, slowing digestion, and promoting satiety
Semaglutide is contraindicated if the patient or a family member have ever had a type of thyroid cancer called medullary thyroid carcinoma (MTC) or an endocrine system condition called Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)
Shukla R, Singh A, Pardhi V, et al (2019) Dendrimer-based nanoparticulate delivery system for cancer therapy
Exercise, especially resistance training, is strongly encouraged while on GLP-1 medications